Histologic Remission: The Ultimate Therapeutic Goal in Ulcerative Colitis?
Open Access
- 5 August 2013
- journal article
- review article
- Published by Elsevier BV in Clinical Gastroenterology and Hepatology
- Vol. 12 (6), 929-934.e2
- https://doi.org/10.1016/j.cgh.2013.07.022
Abstract
No abstract availableKeywords
Funding Information
- Bristol-Myers Squibb
This publication has 36 references indexed in Scilit:
- Early Mucosal Healing With Infliximab Is Associated With Improved Long-term Clinical Outcomes in Ulcerative ColitisGastroenterology, 2011
- Biological and histological parameters as predictors of relapse in ulcerative colitis: A prospective studySaudi Journal of Gastroenterology, 2011
- How Rapidly Should Remission Be Achieved?Digestive Diseases, 2010
- Histopathology Predictors of Medically Refractory Ulcerative ColitisDiseases of the Colon & Rectum, 2010
- Clinical trial: controlled, open, randomized multicentre study comparing the effects of treatment on quality of life, safety and efficacy of budesonide or mesalazine enemas in active left‐sided ulcerative colitisAlimentary Pharmacology & Therapeutics, 2010
- Severity of Inflammation as a Predictor of Colectomy in Patients With Chronic Ulcerative ColitisDiseases of the Colon & Rectum, 2009
- Once daily versus three times daily mesalazine granules in active ulcerative colitis: a double-blind, double-dummy, randomised, non-inferiority trialGut, 2008
- Histologic Inflammation Is a Risk Factor for Progression to Colorectal Neoplasia in Ulcerative Colitis: A Cohort StudyGastroenterology, 2007
- Outcome measurement in clinical trials for ulcerative colitis: towards standardisationTrials, 2007
- Relationship between disease activity indices and colonoscopic findings in patients with colonic inflammatory bowel disease.Gut, 1986